1. Quality of life following pelvic exenteration in neoplasms.
- Author
-
Zanatto RM, Mucci S, Pinheiro RN, de Oliveira JC, Nicolau UR, Domezi JP, Silva DLE, Pracucho EM, Zanatto DO, and Saad SS
- Abstract
Background: Pelvic exenteration (PE) is an extensive surgical treatment reserved for advanced or recurrent pelvic neoplasms, with potential impacts on patients' quality of life (QoL) poorly referenced in the literature., Objectives: This study aimed to evaluate QoL outcomes among three types of PE., Methods: A cross-sectional study assessed 106 patients divided into anterior PE (APE), posterior PE (PPE), or total PE (TPE) groups. QoL was measured using e short form 36 version 2 (SF-36) and the European Organization for Research and Treatment of Cancer QoL Quality of Life Questionnaire Core 30 (QLQ-C30) QoL questionnaires. Descriptive and inferential analyses compared questionnaire scores., Results: The findings unveiled a balance among the three groups concerning demographic variables and comorbidities, with the exception of a male predominance in the APE and TPE cohorts. Notably, the APE group exhibited elevated scores in overall health (assessed via SF-36) and social functioning and diarrhea domains (assessed via QLQ-C30). Moreover, in terms of the fatigue and nausea/vomiting domains (assessed via QLQ-C30), the APE group demonstrated superior QoL compared to the PPE group. Conversely, the PPE group manifested a notably lower QoL in the constipation domain (assessed via QLQ-C30) compared to the other two groups. Additionally, disease recurrence was significantly associated with diminished QoL across multiple domains., Conclusion: APE patients exhibited better QoL than PPE and TPE groups, with disease recurrence adversely affecting QoL., (© 2024 Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF